Biomemory is engineering DNA storage appliances for exabyte-scale data center deployments. The tech stack—Linux, Go, Rust, C++, Docker, Ceph, Terraform, SLURM—reflects a systems-level approach to molecular storage hardware and compute orchestration. Active hiring is concentrated in senior engineering and research roles, with projects spanning device design, production scale-up, and end-to-end sequencing workflows, indicating transition from lab prototype toward manufacturing readiness.
Biomemory builds molecular storage systems targeting enterprises and public-sector organizations with extreme cold-storage requirements. The company develops both DNA-based data storage appliances for data centers and DNA anti-counterfeiting solutions. Founded in 2021 and based in Paris, the 11–50-person team combines hardware engineering, molecular science, and software integration. Current workstreams address the gap between R&D and production: operational procedures, device design iteration, protein purification, and sequencing pipeline reliability.
Biomemory produces DNA-based data storage systems designed as exabyte-rackable appliances for data center deployment, plus DNA anti-counterfeiting systems. Both leverage molecular engineering for cost and energy efficiency.
Linux, Windows, Go, Rust, C++, Docker, Ceph, Terraform, SLURM, Grafana, Prometheus, Ansible, and gRPC. The mix reflects hardware control, containerized workloads, and infrastructure-as-code for data center deployment.
Other companies in the same industry, closest in size